Allergic Bronchopulmonary Aspergillosis
Last Posted: Oct 22, 2017
- F508del CFTR gene mutation in patients with allergic bronchopulmonary aspergillosis.
Gamaletsou Maria N, et al. The Journal of asthma : official journal of the Association for the Care of Asthma 2017 10 1-7
- Effect of allergic bronchopulmonary aspergillosis on FEV1 in children and adolescents with cystic fibrosis: a European Cystic Fibrosis Society Patient Registry analysis.
Kaditis Athanasios G, et al. Archives of disease in childhood 2017 3
- Genetic susceptibility to allergic bronchopulmonary aspergillosis in asthma: a genetic association study.
Overton Nicola L D, et al. Allergy, asthma, and clinical immunology : official journal of the Canadian Society of Allergy and Clinical Immunology 2016 0 47
- Direct Molecular Diagnosis of Aspergillosis and CYP51A Profiling from Respiratory Samples of French Patients.
Zhao Yanan, et al. Frontiers in microbiology 2016 0 1164
- HLA-DRB1 and HLA-DQB1 genes and allergic broncopulmonary aspergillosis susceptibility and protection in patients with cystic fibrosis.
Muro M, et al. Microbiology and immunology 2012 12
- Mannose-binding lectin genotype and serum levels in patients with chronic and allergic pulmonary aspergillosis.
Harrison E, et al. International journal of immunogenetics 2012 6 (3) 224-32
- Link between CFTR mutations and ABPA: a systematic review and meta-analysis.
Agarwal Ritesh, et al. Mycoses 2012 7 (4) 357-65
- Polymorphisms in toll-like receptor genes and susceptibility to pulmonary aspergillosis.
Carvalho A, et al. The Journal of infectious diseases 2008 2 (4) 618-21
- Distinct alleles of mannose-binding lectin (MBL) and surfactant proteins A (SP-A) in patients with chronic cavitary pulmonary aspergillosis and allergic bronchopulmonary aspergillosis.
Vaid Mudit, et al. Clinical chemistry and laboratory medicine : CCLM / FESCC 2007 0 (2) 183-6
- Elevated levels of mannan-binding lectin [corrected] (MBL) and eosinophilia in patients of bronchial asthma with allergic rhinitis and allergic bronchopulmonary aspergillosis associate with a novel intronic polymorphism in MBL.
Kaur S, et al. Clinical and experimental immunology 2006 3 (3) 414-9
- IL-4 alpha chain receptor (IL-4Ralpha) polymorphisms in allergic bronchopulmonary sspergillosis.
Knutsen Alan P, et al. Clinical and molecular allergy : CMA 2006 0 () 3
- HLA-DQB1 *03 in allergic fungal sinusitis and other chronic hypertrophic rhinosinusitis disorders.
Schubert Mark S, et al. The Journal of allergy and clinical immunology 2004 12 (6) 1376-83
- Influence of interleukin-10 on Aspergillus fumigatus infection in patients with cystic fibrosis.
Brouard Jacques, et al. The Journal of infectious diseases 2005 6 (11) 1988-91
- Association of polymorphisms in the collagen region of SP-A2 with increased levels of total IgE antibodies and eosinophilia in patients with allergic bronchopulmonary aspergillosis.
Saxena Shweta, et al. The Journal of allergy and clinical immunology 2003 5 (5) 1001-7
- Frequency of cystic fibrosis transmembrane conductance regulator gene mutations and 5T allele in patients with allergic bronchopulmonary aspergillosis.
Marchand E, et al. Chest 2001 3 (3) 762-7
Selected Rare Diseases
- Alpha-1 Antitrypsin Deficiency
- Amyotrophic Lateral Sclerosis
- Brugada Syndrome
- Cerebral Palsy
- Cystic Fibrosis
- Duchenne Muscular Dystrophy
- Erythema Multiforme
- Familial Mediterranean Fever
- Fragile X Syndrome
- Gaucher Disease
- Graves Disease
- Huntington Disease
- Myasthenia Gravis
- Retinitis Pigmentosa
- Severe Combined Immunodeficiency
Quick Links to Other Resources
Disclaimer: Articles listed in the Public Health Knowledge Base are selected by the CDC Office of Public Health Genomics to provide current awareness of the literature and news. Inclusion in the update does not necessarily represent the views of the Centers for Disease Control and Prevention nor does it imply endorsement of the article's methods or findings. CDC and DHHS assume no responsibility for the factual accuracy of the items presented. The selection, omission, or content of items does not imply any endorsement or other position taken by CDC or DHHS. Opinion, findings and conclusions expressed by the original authors of items included in the update, or persons quoted therein, are strictly their own and are in no way meant to represent the opinion or views of CDC or DHHS. References to publications, news sources, and non-CDC Websites are provided solely for informational purposes and do not imply endorsement by CDC or DHHS.